A wearable remote patient monitoring provider, Biobeat, has launched its new wearable and continuous ambulatory pressure monitoring (ABPM) chest monitoring device.
A blood pressure (BP) measurement has shown to be useful for early prevention and detection of clinical disorders. ABPM can act decisively as an indicator of patient health, to track cardiac data continuously in real-life settings outside the office of the physicians to provide a detailed, unbiased and holistic view of patient health.
The CEO of Biobeat, Arik Ben Ishay said:” As healthcare continues to go digital, the use of ABPM technologies has continued to increase generally across the healthcare sector and will keep growing as we move into the post COVID era. Biobeat is excited to support this trend with our new wearable ABPM solution, giving providers an accurate and continuous real-life view into patient cardiac health, replacing antiquated cuff-based technology.”
The disposable wearable chest monitor includes a patient self-set-up which requires no assistance from a technician or clinician. The device measures systolic and diastolic as well as heart rate, cardiac output, mean arterial pressure, systemic vascular resistance. Measurements can be accessed through the mobile phone of patients through a designated app and are readily available for physicians via an online report analysis web application. By making use of the variety of signs assessed by the Biobeat device, the report allows health care providers to understand the root cause of ‘the identified issues and allow personalized medicine to enable more precise titration and prescription of medications and therapies.
A recently published peer review clinical study compared the Biobeat wearable wrist monitoring device to a standard cuff-based ABPM device discovered that the Biobeat device have the capability to monitor ABPM to the standard cuff based ABPM. Findings demonstrated that cuff inflation leads to high blood pressure values from the standard cuff-based ABPM devices, while the Biobeat wireless wrist monitor is less convenient than the cuff-based device.
Professor Arik Eisenkraft, MD, chief medical officer of Biobeat, said: “In addition to systolic and diastolic BP, Biobeat’s novel ABPM device measures cardiac output, stroke volume, heart rate, mean arterial pressure, and systemic vascular resistance, providing a comprehensive clinical understanding of an individual’s health status. This clinical study highlights the benefit of our device over commonly-used cuff-based ABPM devices, with a remarkable ease-of-use and lack of bias resulting from the mechanical effects of the inflating cuff.”
